DDI Webinar- “Introduction to FDA’s MedWatch Adverse Reporting Program”- February 9, 2016
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all healthcare professionals, pharmacy students, nurse practitioner students, physician assistants, and medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On February 9, 2016, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: "Introduction to FDA’s MedWatch Adverse Reporting Program". The featured speaker, Brenda J. Rose Pharm.D., is a Health Professional Program’s Coordinator in FDA’s Office of Health and Constituent Affairs. She gave an overview of the program, how to report adverse events to FDA MedWatch, and where to find clinically relevant information from Medwatch.
This is Part 1 of 2 Webinars with information on Safety Reporting. Part 2 will be held on February 23, 2016.
Presentation Information
- Introduction to FDAâs MedWatch Adverse Reporting Program
- Introduction to FDAâs MedWatch Adverse Reporting Program